B
Beijing Luzhu Biotechnology Co Ltd
HKEX:2480
Beijing Luzhu Biotechnology Co Ltd
HKEX:2480
Price:
24
HKD
-3.07%
Market Closed
Market Cap:
HK$4.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Beijing Luzhu Biotechnology Co Ltd
HKEX:2480
|
CN |
|
R
|
Rath AG
VSE:RAT
|
AT |
|
P
|
Panda Financial Holding Corp Ltd
SSE:600599
|
CN |
|
S
|
Shenzhen Hongtao Group Co Ltd
SZSE:002325
|
CN |
|
D
|
DE&T Co Ltd
KOSDAQ:079810
|
KR |
|
NHK Spring Co Ltd
TSE:5991
|
JP |
|
B
|
Biohit Oyj
OMXH:BIOBV
|
FI |
|
W
|
Wallbox NV
NYSE:WBX
|
ES |
Multiples-Based Value
The Multiples-Based Value of one Beijing Luzhu Biotechnology Co Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 24 HKD, Beijing Luzhu Biotechnology Co Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Beijing Luzhu Biotechnology Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Beijing Luzhu Biotechnology Co Ltd Competitors
Beijing Luzhu Biotechnology Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
B
|
Beijing Luzhu Biotechnology Co Ltd
HKEX:2480
|
4.8B HKD | 0 | -31.2 | -29.3 | -29.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
366.3B USD | 6.1 | 88.7 | 14.7 | 20.4 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.4B USD | 109.7 | -1 713.1 | 15 914.4 | -1 797 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.8B USD | 5.2 | 24.6 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.6B USD | 5.8 | 20.1 | 12.6 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.6B USD | 9.7 | 29.3 | 22.1 | 23.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.6 | 17.8 | 13.3 | 15.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68B AUD | 3.2 | 35.2 | 11.6 | 14.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
